Supplements and Herbs: Evidence, Interactions, and Quality

What this means

Dietary supplements include vitamins, minerals, herbs, amino acids, and many other ingredients sold as pills, powders, gummies, or liquids. They are meant to supplement the diet. They are not a second, quieter class of approved drugs. That distinction drives everything else: evidence, labeling, and who is responsible when something goes wrong.

FDA regulates supplements, but not the way it regulates prescription drugs. Manufacturers are responsible for safety and labeling before sale. FDA can act after problems appear. The agency does not approve supplements to treat disease. If a longevity clinic talks as if a capsule has been cleared like a drug for your diagnosis, the framing is wrong.

A serious review is narrower than a shopping list. It asks five questions: What product is it, including brand and lot if possible? What dose and form? What condition or deficiency is the intended indication? What medicines, other supplements, and foods might it interact with? What quality testing exists? If any of those five is missing, you do not yet have a review.

Herbs are not automatically gentler than drugs. Plants contain bioactive chemicals. That is why they can have effects, and why they can change drug levels, bleeding risk, blood pressure, or liver tests. Natural is a origin story, not a safety result.

What the evidence shows

ODS consumer materials explain that some supplements are useful for documented deficiencies or specific life stages, while many popular products have mixed or limited evidence for the uses advertised. NCCIH's guidance on using supplements wisely makes the same split: a few clear uses, many uncertain ones, and a standing need to check interactions.

FDA's pages state the legal structure. Supplements cannot legally be marketed to treat, cure, or prevent disease. Structure-function claims are allowed with a disclaimer. That is why you see supports healthy aging language instead of treats coronary disease. The weaker claim is not a loophole that makes the stronger clinical use true. It is a label category.

Interaction evidence is often stronger than benefit evidence. St. John's wort induces drug-metabolizing enzymes and can lower levels of important medicines. Some botanicals and high-dose oils affect bleeding. Licorice can raise blood pressure. Vitamin K antagonizes warfarin. These are not rare trivia. They are reasons a medication list belongs in the same conversation as the herb list.

Quality evidence is also uneven. FDA has found supplements contaminated with drugs, heavy metals, or the wrong plant. Body-building, sexual-enhancement, and weight-loss products are frequent problem categories. Third-party testing can improve confidence in identity and purity. It cannot create outcome data the product never had. A clean bottle of an unproven ingredient is still an unproven ingredient.

Common myths

A common myth is that supplements are FDA-approved if they are on a store shelf. They are not approved for disease treatment, and they are not pre-cleared for effectiveness. Another myth is that if a little is beneficial, more is better. Fat-soluble vitamins and some minerals have toxicity ceilings. Mega-doses are interventions, not insurance.

A third myth is that herbs do not interact because they are food-like. Many foods interact too; herbs are often more concentrated. A fourth myth is that a longevity stack is personalized if it has many bottles. Personalization without an indication, a dose rationale, and an interaction check is just a longer receipt.

Clinics sometimes treat a low-normal lab as a deficiency that requires a proprietary blend. Labs have reference ranges and clinical context. Treating a number that would not change management in primary care is a sales pattern. Another myth is that stopping all supplements is always safest. If you take a clinician-directed product for a documented deficiency, stopping without advice can also cause harm.

Finally, people hear that natural products cannot be contaminated. FDA warning letters and ODS safety notes say otherwise. Mislabeling and adulteration are documented problems. Quality is a test result, not a brand story.

How clinics use it

A careful clinic does a brown-bag review. You bring every bottle. A licensed clinician or pharmacist matches each product to an indication, a dose, and your medicine list. Products without a reason are stopped. Products with interaction risk are stopped or substituted. Deficiency treatment, if needed, uses a defined dose and a follow-up lab when that is the standard of care.

The same clinic is modest about evidence. It will say when a use is established, when it is possible but uncertain, and when it is marketing. It will not tell you a supplement treats cancer, reverses aging, or replaces a prescribed drug. If naturopathic clinicians recommend botanicals, they should still document interactions and stay inside their state scope.

Less careful clinics invert the process. The visit produces a protocol first, then a store. Proprietary blends hide doses. Disease-adjacent claims appear in conversation even if the label is careful. You may be told that testing is optional because the brand is trusted. Trust is not a certificate of analysis.

Ask who profits. Selling supplements is not automatically unethical, but it creates pressure to find a reason for each bottle. You can request that recommendations be limited to products you can buy independently, with published monographs from ODS or NCCIH, and that the clinic write the indication on the plan so you can show it to your primary clinician.

Practical takeaway

Use the five-part review every time: product, dose, indication, medicines, quality testing. If a clinic cannot complete those five, do not start the product. Read FDA and ODS pages if the sales language is moving faster than the evidence.

Tell every clinician and pharmacist what you take, including teas and powders. Do this before surgery and when a new prescription starts. Do not use a supplement as treatment for a disease FDA has not approved it to treat. If you have a diagnosed condition, the treatment plan belongs with a licensed clinician, not with a bottle claim.

Prefer single-ingredient products when a supplement is appropriate, so dose and adverse effects can be tracked. Look for independent testing of identity and contaminants, understanding that this is quality insurance, not proof of benefit. Keep a written stop date and a symptom to watch, including liver, bleeding, and allergy warnings.

Simplifying a stack is often the most useful clinical act. Many people feel better when interactions and duplicate mega-doses are removed. That is not anti-supplement ideology. It is how you keep the few products that have a reason and stop using the rest as a substitute for indicated care.